Stereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard

被引：2
|
作者：
Yalman, Deniz [1 ]
Selek, Ugur [2 ,3 ]
机构：
[1] Ege Univ, Sch Med, Dept Radiat Oncol, 35100 Bornova, Izmir, Turkey
[2] Koc Univ, Sch Med, Dept Radiat Oncol, Istanbul, Turkey
[3] Univ Texas Houston, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77004 USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2015年 / 3卷 / 11期
关键词：
D O I：
10.3978/j.issn.2305-5839.2015.06.23
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Stereotactic ablative body radiotherapy (SABR) for early stage non-small cell lung cancer (NSCLC) at a tertiary referral centre results of the first year of treatment at Birmingham
    Stevenson, R.
    Price, L.
    Webster, G.
    Brennan, M.
    Stange, D.
    Wingate, E.
    Biard, K.
    Ghafoor, Q.
    LUNG CANCER, 2015, 87 : S47 - S47
  • [42] Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data
    Rusthoven, Chad G.
    Kavanagh, Brian D.
    Karam, Sana D.
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (11)
  • [43] Stereotactic ablative radiotherapy with nivolumab for early-stage operable non-small cell lung cancer: A phase 2 study.
    Schvartsman, Gustavo
    Pires de Rezende, Ana Carolina
    Diniz Gomes, Diogo Bugano
    Koch, Ludmila De Oliveira
    Bibas, Benoit Jacques
    Gomes, Oswaldo
    Campregher, Paulo V.
    Severino, Patricia
    Marti, Luciana Cavalheiro
    Paes, Vitor Ribeiro
    Chate, Rodrigo Caruso
    Ribas, Jose Milanez
    Ramos Sousa, Victor Aurelio
    Taranto, Patricia
    Moura, Fernando
    Terra, Ricardo Mingarini
    Samano, Marcos Naoyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] HYPOFRACTIONATED RADIOTHERAPY WITH STEREOTACTIC LOCALIZATION IN EARLY STAGE NON-SMALL CELL LUNG CANCER (NSCLC)
    Salvi, F.
    Donini, E.
    Baldissera, A.
    Degli Esposti, C.
    Martelli, O.
    Monari, F.
    Spagnolli, F.
    Frezza, G.
    Palombarini, M.
    Romagnoli, R.
    LUNG CANCER, 2009, 64 : S48 - S49
  • [45] Stereotactic ablative radiotherapy (SABR) for early stage, medically inoperable non-small cell lung cancer (NSCLC): clinical outcome of 5 years of experience at the Oxford Cancer Centre
    Pascal, L.
    Bull, L.
    Ajzensztejn, D.
    Higgins, G.
    Stuart, R.
    Panakis, N.
    LUNG CANCER, 2018, 115 : S61 - S61
  • [46] The case for SABR as the global standard for non-operable early-stage non-small cell lung cancer
    Mutsaers, Adam
    Louie, Alexander, V
    Moraes, Fabio Ynoe
    LANCET REGIONAL HEALTH-AMERICAS, 2022, 14
  • [47] Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens
    Siva, Shankar
    Ball, David
    ONCOLOGIST, 2016, 21 (04): : 393 - 398
  • [48] Stereotactic body radiotherapy (SBRT) for elderly patients with early stage non-small cell lung cancer (NSCLC)
    Mitsuyoshi, T.
    Kawaguchi, Y.
    Konishi, K.
    Teshima, T.
    Nishiyama, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S809 - S809
  • [49] Standard Conventional Lobectomy vs Stereotactic Body Radiotherapy in Patients with Early Stage Non-Small Cell Lung Cancer (NSCLC) - A Review
    Balakrishnan, P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1007 - S1008
  • [50] A PHASE II TRIAL MEASURING THE INTEGRATION OF STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) PLUS SURGERY IN OPERABLE PATIENTS WITH EARLY NON-SMALL CELL LUNG CANCER (MISSILE-NSCLC): INTERIM SAFETY RESULTS
    Palma, David
    Kwan, Keith
    Gaede, Stewart
    Landis, Mark
    Malthaner, Richard
    Fortin, Dalilah
    Louie, Alexander
    Frechette, Eric
    Rodrigues, George
    Yaremko, Brian
    Yu, Edward
    Dar, Rashid
    Lee, Ting-Yim
    Gratton, Albert
    Ward, Aaron
    Inculet, Richard
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S58 - S58
12345